Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy

Journal of Chemotherapy

Volumn 8, Issue 3, 1996, Pages 237-242

  Massidda, B ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

5 HT3 receptor antagonists; breast cancer; emesis; granisetron; ondansetron; serotonin antagonists; tropisetron

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TROPISETRON;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; VOMITING;

EID: 0029973807     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.3.237     Document Type: Article

References (1)

1. Miner WD, Sanger GJ. Inhibition of cisplatin induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 1986; 88: 497-9.